The Nuclear Medicine and Molecular Medicine podcast Rob Williams

Ratio Therapeutics  with FAPI and moreWe talk with a new company that is harnessing theranostics with ligands we have discussed before https://ratiotx.com/ #Nuccast.com #UniversityofMelbourne #SNMMI #NIF #PET #NuclearMedicine #Podcast #MolecularMedicine #radiochemistry  #theranostics #tracers #Prostate #cancerNuccast.com ,UniversityofMelbourne ,SNMMI ,NIF  ,PET ,NuclearMedicine ,Podcast ,MolecularMedicine, radiochemistry, theragnostics, tracers, Prostate, cancer@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}Please let me know what you think about the video versions of the podcast. I am also looking for new material so please get in touch with me if you can contribute with an interview. Direct link to iTunes https://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2 Older podcasts https://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547 You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/. The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/ Please pass on information about this podcast to your colleagues and to your CPD provider. Link to Video Link to Video file Link to Audio file Link to Audio file Or you can subscribe by entering your email address below and you will be informed of new episodes Enter your email address: Delivered by FeedBurner Most importantly of all please help this podcast by contributing your opinions, Sound files, and emails nucmedpodcast@gmail.com All contributions welcome, especially as sound files to nucmedpodcast@gmail.com.

Ratio Therapeutics with FAPI and moreWe talk with a new company that is harnessing theranostics with ligands we have discussed before https://ratiotx.com/  #Nuccast.com #UniversityofMelbourne #SNMMI #NIF #PET #NuclearMedicine #Podcast #MolecularMedicine #radiochemistry  #theranostics #tracers #Prostate #cancerNuccast.com ,UniversityofMelbourne ,SNMMI ,NIF  ,PET ,NuclearMedicine ,Podcast ,MolecularMedicine, radiochemistry, theragnostics, tracers, Prostate, cancer@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}Please let me know what you think about the video versions of the podcast. I am also looking for new material so please get in touch with me if you can contribute with an interview. Direct link to iTunes https://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2 Older podcasts https://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547 You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/. The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/ Please pass on information about this podcast to your colleagues and to your CPD provider. Link to Video Link to Video file Link to Audio file Link to Audio file Or you can subscribe by entering your email address below and you will be informed of new episodes Enter your email address: Delivered by FeedBurner Most importantly of all please help this podcast by contributing your opinions, Sound files, and emails nucmedpodcast@gmail.com All contributions welcome, especially as sound files to nucmedpodcast@gmail.com.

Oncobeta therapy no imaging needed We talk to a new company now providing therapy using Rhenium 188 for skin cancer. One of the oldest and the newest approaches to Nuclear Medicine. https://www.nuccast.com https://www.oncobeta.com  #Nuccast.com #UniversityofMelbourne #ANZSNM #NIF  #NuclearMedicine #Podcast #MolecularMedicine #radiochemistry  #theranostics #tracers #skincancer  #cancer #bcc #sccc #oncobeta    Nuccast.com,UniversityofMelbourne,ANZSNM,NIF,NuclearMedicine,Podcast,MolecularMedicine,radiochemistry,theranostics,tracers,skincancer,cancer,bcc,sccc, oncobeta @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-536859905 -1073732485 9 0 511 0;}@font-face {font-family:AppleSystemUIFont; panose-1:2 11 6 4 2 2 2 2 2 4; mso-font-alt:Calibri; mso-font-charset:0; mso-generic-font-family:auto; mso-font-pitch:auto; mso-font-signature:3 0 0 0 1 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-536859905 -1073732485 9 0 511 0;}@font-face {font-family:AppleSystemUIFont; panose-1:2 11 6 4 2 2 2 2 2 4; mso-font-alt:Calibri; mso-font-charset:0; mso-generic-font-family:auto; mso-font-pitch:auto; mso-font-signature:3 0 0 0 1 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; ms

Oncobeta therapy no imaging needed We talk to a new company now providing therapy using Rhenium 188 for skin cancer. One of the oldest and the newest approaches to Nuclear Medicine https://www.nuccast.com https://www.oncobeta.com  #Nuccast.com #UniversityofMelbourne #ANZSNM #NIF  #NuclearMedicine #Podcast #MolecularMedicine #radiochemistry  #theranostics #tracers #skincancer  #cancer #bcc #sccc #oncobeta    Nuccast.com,UniversityofMelbourne,ANZSNM,NIF,NuclearMedicine,Podcast,MolecularMedicine,radiochemistry,theranostics,tracers,skincancer,cancer,bcc,sccc, oncobeta @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-536859905 -1073732485 9 0 511 0;}@font-face {font-family:AppleSystemUIFont; panose-1:2 11 6 4 2 2 2 2 2 4; mso-font-alt:Calibri; mso-font-charset:0; mso-generic-font-family:auto; mso-font-pitch:auto; mso-font-signature:3 0 0 0 1 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;} @font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}@font-face {font-family:Calibri; panose-1:2 15 5 2 2 2 4 3 2 4; mso-font-charset:0; mso-generic-font-family:swiss; mso-font-pitch:variable; mso-font-signature:-536859905 -1073732485 9 0 511 0;}@font-face {font-family:AppleSystemUIFont; panose-1:2 11 6 4 2 2 2 2 2 4; mso-font-alt:Calibri; mso-font-charset:0; mso-generic-font-family:auto; mso-font-pitch:auto; mso-font-signature:3 0 0 0 1 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso

Dosimetry for everyone! Panel discussionWe discuss the hot topic of dosimetry for theranostics. Much debate around. Apologies on the length of this one, but its worthy of a long discussion.1. Do we need to do it before doing therapy?2. Can we do it?3. But there are problems with it?4. How to get started?and much more  https://www.nuccast.com  Nuccast.com #UniversityofMelbourne #ANZSNM #NIF #PET #NuclearMedicine #Podcast #MolecularMedicine #radiochemistry  #theragnostics #tracers #Prostate #cancerNuccast.com ,UniversityofMelbourne ,SNMMI ,NIF  ,PET ,NuclearMedicine ,Podcast ,MolecularMedicine, radiochemistry, theragnostics, tracers, Prostate, cancer@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}Please let me know what you think about the video versions of the podcast. I am also looking for new material so please get in touch with me if you can contribute with an interview. Direct link to iTunes https://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2 Older podcasts https://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547 You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/. The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/ Please pass on information about this podcast to your colleagues and to your CPD provider. Link to Video Link to Video file Link to Audio file Link to Audio file Or you can subscribe by entering your email address below and you will be informed of new episodes Enter your email address: Delivered by FeedBurner Most importantly of all please help this podcast by contributing your opinions, Sound files, and emails nucmedpodcast@gmail.com All contributions welcome, especially as sound files to nucmedpodcast@gmail.com.

Dosimetry for everyone! Panel discussion We discuss the hot topic of dosimetry for theranostics. Much debate around. Apologies on the length of this one, but its worthy of a long discussion.1. Do we need to do it before doing therapy?2. Can we do it?3. But there are problems with it?4. How to get started?and much more  https://www.nuccast.com  Nuccast.com #UniversityofMelbourne #ANZSNM #NIF #PET #NuclearMedicine #Podcast #MolecularMedicine #radiochemistry  #theragnostics #tracers #Prostate #cancerNuccast.com ,UniversityofMelbourne ,SNMMI ,NIF  ,PET ,NuclearMedicine ,Podcast ,MolecularMedicine, radiochemistry, theragnostics, tracers, Prostate, cancer@font-face {font-family:"Cambria Math"; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-536870145 1107305727 0 0 415 0;}p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:""; margin:0cm; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman",serif; mso-fareast-font-family:"Times New Roman";}.MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-family:"Calibri",sans-serif; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:Calibri; mso-fareast-theme-font:minor-latin; mso-hansi-font-family:Calibri; mso-hansi-theme-font:minor-latin; mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi; mso-ansi-language:EN-GB; mso-fareast-language:EN-US;}div.WordSection1 {page:WordSection1;}Please let me know what you think about the video versions of the podcast. I am also looking for new material so please get in touch with me if you can contribute with an interview. Direct link to iTunes https://itunes.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicinie-podcast/id1444565219?mt=2 Older podcasts https://podcasts.apple.com/au/podcast/the-nuclear-medicine-and-molecular-medicine-podcast/id94286547 You can get the podcast page at both http://nuccast.com and http://www.nuccast.com with the feed to put into iTunes or juice or your favourite podcast software can be found at http://molcast.com/. The cardiac subset of the podcast can be found at http://cardiac.nuccast.com/ Please pass on information about this podcast to your colleagues and to your CPD provider. Link to Video Link to Video file Link to Audio file Link to Audio file Or you can subscribe by entering your email address below and you will be informed of new episodes Enter your email address: Delivered by FeedBurner Most importantly of all please help this podcast by contributing your opinions, Sound files, and emails nucmedpodcast@gmail.com All contributions welcome, especially as sound files to nucmedpodcast@gmail.com.